nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxprenolol—ADRB1—Adrenoceptors—ADRA2C—attention deficit hyperactivity disorder	0.0524	0.054	CbGpPWpGaD
Oxprenolol—ADRB2—Adrenoceptors—ADRA2C—attention deficit hyperactivity disorder	0.0512	0.0529	CbGpPWpGaD
Oxprenolol—ADRB1—Adrenoceptors—ADRA2A—attention deficit hyperactivity disorder	0.0275	0.0284	CbGpPWpGaD
Oxprenolol—SLC22A2—Neurotransmitter Clearance In The Synaptic Cleft—SLC6A3—attention deficit hyperactivity disorder	0.0269	0.0278	CbGpPWpGaD
Oxprenolol—ADRB2—Adrenoceptors—ADRA2A—attention deficit hyperactivity disorder	0.0269	0.0278	CbGpPWpGaD
Oxprenolol—SLC22A2—Neurotransmitter Clearance In The Synaptic Cleft—COMT—attention deficit hyperactivity disorder	0.0229	0.0236	CbGpPWpGaD
Oxprenolol—SLC22A2—Neurotransmitter Clearance In The Synaptic Cleft—MAOA—attention deficit hyperactivity disorder	0.0227	0.0235	CbGpPWpGaD
Oxprenolol—ADRB1—Monoamine GPCRs—ADRA2C—attention deficit hyperactivity disorder	0.0185	0.0191	CbGpPWpGaD
Oxprenolol—ADRB1—Monoamine GPCRs—DRD5—attention deficit hyperactivity disorder	0.0181	0.0187	CbGpPWpGaD
Oxprenolol—ADRB2—Monoamine GPCRs—ADRA2C—attention deficit hyperactivity disorder	0.0181	0.0187	CbGpPWpGaD
Oxprenolol—ADRB2—Monoamine GPCRs—DRD5—attention deficit hyperactivity disorder	0.0178	0.0183	CbGpPWpGaD
Oxprenolol—SLC22A2—Norepinephrine Neurotransmitter Release Cycle—SNAP25—attention deficit hyperactivity disorder	0.0158	0.0163	CbGpPWpGaD
Oxprenolol—ADRB1—Amine ligand-binding receptors—ADRA2C—attention deficit hyperactivity disorder	0.0156	0.0161	CbGpPWpGaD
Oxprenolol—ADRB1—Amine ligand-binding receptors—DRD5—attention deficit hyperactivity disorder	0.0153	0.0157	CbGpPWpGaD
Oxprenolol—ADRB2—Amine ligand-binding receptors—ADRA2C—attention deficit hyperactivity disorder	0.0152	0.0157	CbGpPWpGaD
Oxprenolol—ADRB2—Amine ligand-binding receptors—DRD5—attention deficit hyperactivity disorder	0.0149	0.0154	CbGpPWpGaD
Oxprenolol—Penbutolol—HTR1B—attention deficit hyperactivity disorder	0.0146	0.473	CrCbGaD
Oxprenolol—SLC22A2—Na+/Cl- dependent neurotransmitter transporters—SLC6A3—attention deficit hyperactivity disorder	0.0135	0.0139	CbGpPWpGaD
Oxprenolol—SLC22A2—Norepinephrine Neurotransmitter Release Cycle—MAOA—attention deficit hyperactivity disorder	0.0119	0.0123	CbGpPWpGaD
Oxprenolol—ADRB1—Monoamine GPCRs—HTR1B—attention deficit hyperactivity disorder	0.011	0.0113	CbGpPWpGaD
Oxprenolol—ADRB2—Monoamine GPCRs—HTR1B—attention deficit hyperactivity disorder	0.0108	0.0111	CbGpPWpGaD
Oxprenolol—ADRB1—Amine ligand-binding receptors—HRH3—attention deficit hyperactivity disorder	0.0106	0.0109	CbGpPWpGaD
Oxprenolol—Pindolol—HTR1B—attention deficit hyperactivity disorder	0.0105	0.341	CrCbGaD
Oxprenolol—ADRB2—Amine ligand-binding receptors—HRH3—attention deficit hyperactivity disorder	0.0103	0.0107	CbGpPWpGaD
Oxprenolol—ADRB1—Monoamine GPCRs—DRD1—attention deficit hyperactivity disorder	0.0102	0.0105	CbGpPWpGaD
Oxprenolol—ADRB2—Monoamine GPCRs—DRD1—attention deficit hyperactivity disorder	0.01	0.0103	CbGpPWpGaD
Oxprenolol—ADRB1—Monoamine GPCRs—DRD3—attention deficit hyperactivity disorder	0.0099	0.0102	CbGpPWpGaD
Oxprenolol—ADRB1—Monoamine GPCRs—ADRA2A—attention deficit hyperactivity disorder	0.00973	0.01	CbGpPWpGaD
Oxprenolol—ADRB2—Monoamine GPCRs—DRD3—attention deficit hyperactivity disorder	0.00968	0.00999	CbGpPWpGaD
Oxprenolol—ADRB1—Monoamine GPCRs—DRD4—attention deficit hyperactivity disorder	0.00961	0.00992	CbGpPWpGaD
Oxprenolol—ADRB2—Monoamine GPCRs—ADRA2A—attention deficit hyperactivity disorder	0.00952	0.00982	CbGpPWpGaD
Oxprenolol—ADRB2—Monoamine GPCRs—DRD4—attention deficit hyperactivity disorder	0.0094	0.0097	CbGpPWpGaD
Oxprenolol—SLC22A2—Amine compound SLC transporters—SLC6A3—attention deficit hyperactivity disorder	0.00936	0.00965	CbGpPWpGaD
Oxprenolol—ADRB1—Amine ligand-binding receptors—HTR1B—attention deficit hyperactivity disorder	0.00924	0.00954	CbGpPWpGaD
Oxprenolol—ADRB2—Amine ligand-binding receptors—HTR1B—attention deficit hyperactivity disorder	0.00904	0.00933	CbGpPWpGaD
Oxprenolol—ADRB1—Monoamine GPCRs—DRD2—attention deficit hyperactivity disorder	0.00895	0.00924	CbGpPWpGaD
Oxprenolol—ADRB2—Monoamine GPCRs—DRD2—attention deficit hyperactivity disorder	0.00876	0.00904	CbGpPWpGaD
Oxprenolol—ADRB1—Amine ligand-binding receptors—DRD1—attention deficit hyperactivity disorder	0.00859	0.00887	CbGpPWpGaD
Oxprenolol—ADRB1—Melatonin metabolism and effects—MAOA—attention deficit hyperactivity disorder	0.00853	0.0088	CbGpPWpGaD
Oxprenolol—ADRB2—Amine ligand-binding receptors—DRD1—attention deficit hyperactivity disorder	0.00841	0.00867	CbGpPWpGaD
Oxprenolol—ADRB1—Amine ligand-binding receptors—DRD3—attention deficit hyperactivity disorder	0.00832	0.00859	CbGpPWpGaD
Oxprenolol—ADRB1—Amine ligand-binding receptors—ADRA2A—attention deficit hyperactivity disorder	0.00818	0.00844	CbGpPWpGaD
Oxprenolol—ADRB2—Amine ligand-binding receptors—DRD3—attention deficit hyperactivity disorder	0.00814	0.0084	CbGpPWpGaD
Oxprenolol—ADRB1—Amine ligand-binding receptors—DRD4—attention deficit hyperactivity disorder	0.00808	0.00834	CbGpPWpGaD
Oxprenolol—SLC22A2—Neurotransmitter Release Cycle—SNAP25—attention deficit hyperactivity disorder	0.00802	0.00828	CbGpPWpGaD
Oxprenolol—ADRB2—Amine ligand-binding receptors—ADRA2A—attention deficit hyperactivity disorder	0.008	0.00826	CbGpPWpGaD
Oxprenolol—ADRB2—Amine ligand-binding receptors—DRD4—attention deficit hyperactivity disorder	0.0079	0.00815	CbGpPWpGaD
Oxprenolol—ADRB1—Amine ligand-binding receptors—DRD2—attention deficit hyperactivity disorder	0.00753	0.00776	CbGpPWpGaD
Oxprenolol—ADRB2—Amine ligand-binding receptors—DRD2—attention deficit hyperactivity disorder	0.00736	0.0076	CbGpPWpGaD
Oxprenolol—ADRB1—G alpha (s) signalling events—DRD5—attention deficit hyperactivity disorder	0.00629	0.00649	CbGpPWpGaD
Oxprenolol—ADRB1—Monoamine GPCRs—HTR2A—attention deficit hyperactivity disorder	0.00627	0.00647	CbGpPWpGaD
Oxprenolol—ADRB2—G alpha (s) signalling events—DRD5—attention deficit hyperactivity disorder	0.00616	0.00635	CbGpPWpGaD
Oxprenolol—ADRB2—Monoamine GPCRs—HTR2A—attention deficit hyperactivity disorder	0.00613	0.00633	CbGpPWpGaD
Oxprenolol—SLC22A2—Neurotransmitter Release Cycle—MAOA—attention deficit hyperactivity disorder	0.00604	0.00623	CbGpPWpGaD
Oxprenolol—Propranolol—HTR1B—attention deficit hyperactivity disorder	0.00573	0.186	CrCbGaD
Oxprenolol—SLC22A2—Transmission across Chemical Synapses—GABRQ—attention deficit hyperactivity disorder	0.00562	0.0058	CbGpPWpGaD
Oxprenolol—ADRB1—Amine ligand-binding receptors—HTR2A—attention deficit hyperactivity disorder	0.00527	0.00544	CbGpPWpGaD
Oxprenolol—ADRB2—Amine ligand-binding receptors—HTR2A—attention deficit hyperactivity disorder	0.00516	0.00532	CbGpPWpGaD
Oxprenolol—SLC22A2—SLC-mediated transmembrane transport—SLC9A9—attention deficit hyperactivity disorder	0.00478	0.00493	CbGpPWpGaD
Oxprenolol—SLC22A2—Neuronal System—GABRQ—attention deficit hyperactivity disorder	0.00431	0.00445	CbGpPWpGaD
Oxprenolol—ADRB2—GPCRs, Other—DRD3—attention deficit hyperactivity disorder	0.0043	0.00444	CbGpPWpGaD
Oxprenolol—CYP2D6—Melatonin metabolism and effects—MAOA—attention deficit hyperactivity disorder	0.00418	0.00431	CbGpPWpGaD
Oxprenolol—ADRB2—GPCRs, Other—DRD4—attention deficit hyperactivity disorder	0.00418	0.00431	CbGpPWpGaD
Oxprenolol—SLC22A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—attention deficit hyperactivity disorder	0.00366	0.00378	CbGpPWpGaD
Oxprenolol—ADRB1—GPCRs, Class A Rhodopsin-like—ADRA2C—attention deficit hyperactivity disorder	0.00357	0.00369	CbGpPWpGaD
Oxprenolol—ADRB1—G alpha (s) signalling events—DRD1—attention deficit hyperactivity disorder	0.00354	0.00366	CbGpPWpGaD
Oxprenolol—ADRB1—GPCRs, Class A Rhodopsin-like—DRD5—attention deficit hyperactivity disorder	0.0035	0.00361	CbGpPWpGaD
Oxprenolol—ADRB1—Calcium Regulation in the Cardiac Cell—CACNA1C—attention deficit hyperactivity disorder	0.0035	0.00361	CbGpPWpGaD
Oxprenolol—ADRB2—GPCRs, Class A Rhodopsin-like—ADRA2C—attention deficit hyperactivity disorder	0.0035	0.00361	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR ligand binding—GRM7—attention deficit hyperactivity disorder	0.00348	0.00359	CbGpPWpGaD
Oxprenolol—ADRB2—G alpha (s) signalling events—DRD1—attention deficit hyperactivity disorder	0.00347	0.00358	CbGpPWpGaD
Oxprenolol—ADRB2—GPCRs, Class A Rhodopsin-like—DRD5—attention deficit hyperactivity disorder	0.00343	0.00353	CbGpPWpGaD
Oxprenolol—ADRB2—Calcium Regulation in the Cardiac Cell—CACNA1C—attention deficit hyperactivity disorder	0.00343	0.00353	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR ligand binding—GRM7—attention deficit hyperactivity disorder	0.0034	0.00351	CbGpPWpGaD
Oxprenolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—ADRA2C—attention deficit hyperactivity disorder	0.00306	0.00316	CbGpPWpGaD
Oxprenolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD5—attention deficit hyperactivity disorder	0.003	0.0031	CbGpPWpGaD
Oxprenolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—ADRA2C—attention deficit hyperactivity disorder	0.003	0.00309	CbGpPWpGaD
Oxprenolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD5—attention deficit hyperactivity disorder	0.00294	0.00303	CbGpPWpGaD
Oxprenolol—SLC22A2—Transmission across Chemical Synapses—CACNB2—attention deficit hyperactivity disorder	0.00288	0.00297	CbGpPWpGaD
Oxprenolol—ADRB2—GPCRs, Other—HTR2A—attention deficit hyperactivity disorder	0.00272	0.00281	CbGpPWpGaD
Oxprenolol—SLC22A2—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.00248	0.00255	CbGpPWpGaD
Oxprenolol—SLC22A2—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.00243	0.00251	CbGpPWpGaD
Oxprenolol—ADRB1—GPCRs, Class A Rhodopsin-like—HRH3—attention deficit hyperactivity disorder	0.00243	0.0025	CbGpPWpGaD
Oxprenolol—ADRB2—GPCRs, Class A Rhodopsin-like—HRH3—attention deficit hyperactivity disorder	0.00237	0.00245	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.00233	0.00241	CbGpPWpGaD
Oxprenolol—SLC22A2—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.00232	0.00239	CbGpPWpGaD
Oxprenolol—SLC22A2—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.0023	0.00237	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.00228	0.00236	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.00228	0.00235	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.00224	0.00231	CbGpPWpGaD
Oxprenolol—SLC22A2—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.00221	0.00228	CbGpPWpGaD
Oxprenolol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.00212	0.00219	CbGpPWpGaD
Oxprenolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.00208	0.00215	CbGpPWpGaD
Oxprenolol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.00208	0.00214	CbGpPWpGaD
Oxprenolol—SLC22A2—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.00205	0.00212	CbGpPWpGaD
Oxprenolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.00203	0.0021	CbGpPWpGaD
Oxprenolol—ADRB1—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.00197	0.00204	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.00197	0.00203	CbGpPWpGaD
Oxprenolol—ADRB2—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.00193	0.00199	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.00192	0.00198	CbGpPWpGaD
Oxprenolol—ADRB1—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.00191	0.00197	CbGpPWpGaD
Oxprenolol—SLC22A2—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.0019	0.00196	CbGpPWpGaD
Oxprenolol—CYP2D6—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.00189	0.00195	CbGpPWpGaD
Oxprenolol—ADRB1—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.00188	0.00194	CbGpPWpGaD
Oxprenolol—ADRB2—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.00187	0.00193	CbGpPWpGaD
Oxprenolol—ADRB1—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.00185	0.00191	CbGpPWpGaD
Oxprenolol—ADRB2—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.00184	0.0019	CbGpPWpGaD
Oxprenolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.00182	0.00188	CbGpPWpGaD
Oxprenolol—ADRB2—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.00181	0.00187	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.00178	0.00184	CbGpPWpGaD
Oxprenolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.00178	0.00183	CbGpPWpGaD
Oxprenolol—SLC22A2—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.00176	0.00182	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.00175	0.0018	CbGpPWpGaD
Oxprenolol—SLC22A2—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.00174	0.0018	CbGpPWpGaD
Oxprenolol—SLC22A2—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.00173	0.00179	CbGpPWpGaD
Oxprenolol—ADRB1—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.00173	0.00178	CbGpPWpGaD
Oxprenolol—ADRB2—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.00169	0.00174	CbGpPWpGaD
Oxprenolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.00169	0.00174	CbGpPWpGaD
Oxprenolol—SLC22A2—SLC-mediated transmembrane transport—SLC6A3—attention deficit hyperactivity disorder	0.00166	0.00172	CbGpPWpGaD
Oxprenolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.00165	0.00171	CbGpPWpGaD
Oxprenolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.00164	0.00169	CbGpPWpGaD
Oxprenolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.00161	0.00166	CbGpPWpGaD
Oxprenolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.0016	0.00165	CbGpPWpGaD
Oxprenolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.00159	0.00164	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.00158	0.00163	CbGpPWpGaD
Oxprenolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.00157	0.00162	CbGpPWpGaD
Oxprenolol—SLC22A2—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.00157	0.00162	CbGpPWpGaD
Oxprenolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.00155	0.0016	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.00155	0.0016	CbGpPWpGaD
Oxprenolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.00148	0.00153	CbGpPWpGaD
Oxprenolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.00145	0.00149	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.00138	0.00143	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.00135	0.0014	CbGpPWpGaD
Oxprenolol—SLC22A2—Neuronal System—COMT—attention deficit hyperactivity disorder	0.00134	0.00138	CbGpPWpGaD
Oxprenolol—SLC22A2—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.00133	0.00137	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.00132	0.00136	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.00129	0.00133	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.00129	0.00133	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.00129	0.00133	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.00126	0.0013	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.00126	0.0013	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.00125	0.00129	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.00123	0.00126	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.00122	0.00126	CbGpPWpGaD
Oxprenolol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.00121	0.00125	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.00121	0.00125	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.0012	0.00124	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.0012	0.00123	CbGpPWpGaD
Oxprenolol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.00118	0.00122	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.00118	0.00122	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.00117	0.00121	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.00117	0.00121	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.00115	0.00118	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.00113	0.00116	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.0011	0.00114	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.00105	0.00109	CbGpPWpGaD
Oxprenolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.00104	0.00107	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.00103	0.00106	CbGpPWpGaD
Oxprenolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.00101	0.00105	CbGpPWpGaD
Oxprenolol—CYP2D6—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.00101	0.00105	CbGpPWpGaD
Oxprenolol—CYP2D6—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.00101	0.00104	CbGpPWpGaD
Oxprenolol—CYP2D6—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000999	0.00103	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.000895	0.000923	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.000876	0.000903	CbGpPWpGaD
Oxprenolol—SLC22A2—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000845	0.000872	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000823	0.000849	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.000813	0.000839	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000805	0.000831	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000805	0.00083	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.000795	0.00082	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.000789	0.000815	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.000782	0.000807	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.000772	0.000797	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.000765	0.00079	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.000727	0.00075	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.000711	0.000734	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.00071	0.000733	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000707	0.00073	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.000704	0.000727	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000695	0.000717	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000693	0.000715	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.000692	0.000714	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000692	0.000714	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.000689	0.000711	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000684	0.000706	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000679	0.000701	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000678	0.000699	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.000677	0.000699	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000669	0.00069	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000664	0.000686	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.00066	0.000681	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000646	0.000667	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.00064	0.00066	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000637	0.000657	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000629	0.000649	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000626	0.000646	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000623	0.000643	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000621	0.000641	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000615	0.000635	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000607	0.000627	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000578	0.000597	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000566	0.000584	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000555	0.000573	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000555	0.000573	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000546	0.000564	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000508	0.000524	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.00048	0.000495	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.00047	0.000485	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000446	0.00046	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000444	0.000458	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000436	0.00045	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000423	0.000436	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.00042	0.000433	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000414	0.000427	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000411	0.000424	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000405	0.000418	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000396	0.000409	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.00039	0.000403	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000382	0.000394	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000378	0.00039	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000371	0.000383	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.00037	0.000381	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000367	0.000378	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000363	0.000375	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000359	0.00037	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000342	0.000353	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—COMT—attention deficit hyperactivity disorder	0.000336	0.000347	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000334	0.000345	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000334	0.000345	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000286	0.000295	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000286	0.000295	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000281	0.00029	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000262	0.00027	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000239	0.000247	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000234	0.000242	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000229	0.000236	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000218	0.000225	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—COMT—attention deficit hyperactivity disorder	0.000173	0.000179	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000172	0.000177	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—EP300—attention deficit hyperactivity disorder	0.000144	0.000149	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000127	0.000131	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000124	0.000128	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—EP300—attention deficit hyperactivity disorder	7.43e-05	7.66e-05	CbGpPWpGaD
